Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Brovale: Letrozole for Fertility Preservation in Breast Cancer
NCT02661932Phase 4Completed
- Sponsor
- Erasmus Hospital
- Start
- Nov 2012
- Primary completion
- Mar 2018
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
Phase 4, open-label, single-arm trial of letrozole in breast cancer, sponsored by Erasmus Hospital. Primary endpoint: Oocyte maturation rate. Started Nov 2012; status: completed.
02
Drugs
letrozole
03
Conditions
breast cancer
Beyond the preview
Go deeper on NCT02661932.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02661932.